Satellos Bioscience Inc (MSCLF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,340 | 1,070 | 590 | 250 | N/A |
| Marketable Securities | 1,820 | 770 | 660 | 1,080 | N/A |
| Receivables | 30 | 120 | 20 | 20 | N/A |
| Other current assets | 40 | 40 | 60 | 60 | 0 |
| TOTAL | $5,230 | $2,000 | $1,330 | $1,410 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 5 | 6 | 8 | 8 | N/A |
| Investments And Advances | 1,120 | 1,650 | 1,430 | 1,230 | 0 |
| Other Non-Current Assets | 50 | 140 | 230 | 320 | 0 |
| TOTAL | $1,175 | $1,796 | $1,668 | $1,558 | $N/A |
| Total Assets | $6,410 | $3,810 | $3,010 | $2,980 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,420 | 2,550 | 960 | 250 | 0 |
| TOTAL | $1,420 | $2,550 | $960 | $250 | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,420 | $2,550 | $960 | $250 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,223 | 3,391 | N/A | N/A | N/A |
| Common Shares | 25,410 | 23,150 | 19,990 | 17,790 | N/A |
| Retained earnings | -26,110 | -26,040 | -21,150 | -17,710 | N/A |
| Other shareholders' equity | 2,520 | 1,090 | 810 | 390 | 0 |
| TOTAL | $4,980 | $1,260 | $2,050 | $2,720 | $N/A |
| Total Liabilities And Equity | $6,400 | $3,810 | $3,010 | $2,970 | $0 |